Table 1. Histology and Immunohistochemistry.
Groups | Cell density indexa | Significanceb | Apoptotic indexc | Significanceb |
---|---|---|---|---|
Controls | 0.242 ± 0.014 | 0.0341 ±0.003 | ||
Daily dose | 0.166 ± 0.009 | P < 0.050 | 0.0344 ± 0.004 | P > 0.050 |
Pulsed dose | 0.145 ± 0.008 | P < 0.050 | 0.0321 ± 0.004 | P > 0.050 |
A cell density index derived from H&E slides as the ratio of the area occupied by cells in a given field to the total field area, revealed that both gefitinib treatment groups were significantly less dense than the control group. Means and standard error are provided for each group in the gefitinib treatment study.
P-values reflect difference from controls.
An apoptotic index derived from caspase-3-stained slides as the ratio of apoptosis stained cells in a given field to the total number of cells in the field, revealed no significant differences in apoptosis between groups in the gefitinib treatment study.